SCHEMBL346282

SCHEMBL346282

[O]c1cccc2snnc12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15686693 0.75 GABRA1 (0.40)
SCHEMBL29942154 0.74 BACE1 (0.35)
SCHEMBL289346 0.74 ALDH1A1 (0.46)
SCHEMBL289345 0.74
SCHEMBL4615662 0.74 F9 (0.30)
SCHEMBL5355939 0.74
SCHEMBL5353984 0.72 MAPT (0.33)
SCHEMBL3739493 0.72 ALDH1A1 (0.44)
SCHEMBL28487213 0.71 NSD2 (0.33)
SCHEMBL19328412 0.71 FBP1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111989317-B Polymerizable liquid crystal compound, polymerizable liquid crystal composition, polymer, optical film, optically anisotropic body, and polarizing plate 日本瑞翁株式会社 2023-12-01 CN disclosed
US-11829036-B2 Optically anisotropic multilayer product and method for producing same ZEON CORPORATION (JP) 2023-11-28 US disclosed
WO-2023132369-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND HAVING NRF2 ACTIVATION EFFECT 中外製薬株式会社 2023-07-13 WO disclosed
CN-111602077-B Composition, phase difference film, and method for producing phase difference film 日本瑞翁株式会社 2022-06-14 CN disclosed
CN-114424114-A Optically anisotropic multilayer body and method for producing same 日本瑞翁株式会社 2022-04-29 CN disclosed
CN-110392703-B Polymerizable compound and method for producing same, polymerizable composition, polymer, optical film, and optically anisotropic body 日本瑞翁株式会社 2022-02-01 CN disclosed
US-20210198574-A1 COMPOSITION, RETARDATION FILM, AND METHOD FOR PRODUCING RETARDATION FILM ZEON CORPORATION (JP) 2021-07-01 US disclosed
CN-111989317-A Polymerizable liquid crystal compound, polymerizable liquid crystal composition, polymer, optical film, optically anisotropic body, polarizing plate, display device, and antireflection film 日本瑞翁株式会社 2020-11-24 CN disclosed
CN-111602077-A Composition, phase difference film, and method for producing phase difference film 日本瑞翁株式会社 2020-08-28 CN disclosed
US-20200262801-A1 POLYMERIZABLE COMPOUND AND A PRODUCTION METHOD FOR SAME, POLYMERIZABLE COMPOSITION, POLYMER, OPTICAL FILM, OPTICAILLY ANISOTROPIC BODY, POLARIZING PLATE, DISPLAY DEVICE, ANTIREFLECTION FILM, AND COMPOUND AND USE FOR SAME ZEON CORPORATION (JP) 2020-08-20 US disclosed
US-20060241171-A1 Novel physiologically active substances MICROBIOPHARM JAPAN CO., LTD. (JP) 2006-10-26 US disclosed
US-20060235002-A1 Novel physiologically active substance EISAI R&D MANAGEMENT CO., LTD. (JP) 2006-10-19 US disclosed
EP-1710244-A1 METHOD OF STABILIZING MACROLIDE COMPOUND Eisai R&D Management Co., Ltd. (JP) 2006-10-11 EP disclosed
EP-1705247-A1 DNA PARTICIPATING IN HYDROXYLATION OF MACROLIDE COMPOUND MERCIAN CORPORATION (JP) 2006-09-27 EP disclosed
US-20060009439-A1 Novel physiologically active substances MERCIAN CORPORATION (JP) 2006-01-12 US disclosed
US-20050245514-A1 Novel physiologically active substances MICROBIOPHARM JAPAN CO., LTD. (JP) 2005-11-03 US disclosed
US-20050227959-A1 Heterocyclic compound having oxime group EISAI CO., LTD. (JP) 2005-10-13 US disclosed
EP-1548121-A1 NOVEL PHYSIOLOGICALLY ACTIVE SUBSTANCES MERCIAN CORPORATION (JP) 2005-06-29 EP disclosed
EP-1541570-A1 NOVEL PHYSIOLOGICALLY ACTIVE SUBSTANCE MERCIAN CORPORATION (JP) 2005-06-15 EP disclosed
EP-1508570-A1 NOVEL PHYSIOLGICALLY ACTIVE SUBSTANCES MERCIAN CORPORATION (JP) 2005-02-23 EP disclosed